Letrozole treatment of adult female mice results in a similar reproductive phenotype but distinct changes in metabolism and the gut microbiome compared to pubertal mice
Abstract Background A majority of women with polycystic ovary syndrome (PCOS) have metabolic dysfunction that results in an increased risk of type 2 diabetes. We previously developed a pubertal mouse model using the aromatase inhibitor, letrozole, which recapitulates many of the reproductive and met...
Main Authors: | Pedro J. Torres, Danalea V. Skarra, Bryan S. Ho, Lillian Sau, Arya R. Anvar, Scott T. Kelley, Varykina G. Thackray |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | BMC Microbiology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12866-019-1425-7 |
Similar Items
-
Efficiency of modern correction methods of ovarian hyperandrogenism in puberty
by: E M Alieva, et al.
Published: (2018-12-01) -
An Investigation of Biochemical and Structural Changes in Reproductive System Hyperandrogenism in Experimental Letrozole-induced Polycystic Ovary Syndrome in Rat
by: Azam Soleimani, et al.
Published: (2016-11-01) -
Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
by: Pablo Arroyo, et al.
Published: (2019-01-01) -
Gene Variants Are Associated with PCOS Susceptibility and Hyperandrogenemia in Young Korean Women
by: Do Kyeong Song, et al.
Published: (2014-08-01) -
The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome
by: Carlo Alviggi, et al.
Published: (2017-05-01)